Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Sensitivity shift theory: A developmental model of positive affect and motivational deficits in social anxiety disorder.

Richey JA, Brewer JA, Sullivan-Toole H, Strege MV, Kim-Spoon J, White SW, Ollendick TH.

Clin Psychol Rev. 2019 Aug;72:101756. doi: 10.1016/j.cpr.2019.101756. Epub 2019 Jul 18. Review.

PMID:
31351312
2.

Quitting starts in the brain: a randomized controlled trial of app-based mindfulness shows decreases in neural responses to smoking cues that predict reductions in smoking.

Janes AC, Datko M, Roy A, Barton B, Druker S, Neal C, Ohashi K, Benoit H, van Lutterveld R, Brewer JA.

Neuropsychopharmacology. 2019 Aug;44(9):1631-1638. doi: 10.1038/s41386-019-0403-y. Epub 2019 Apr 30.

PMID:
31039580
3.

From research to clinic: A sensor reduction method for high-density EEG neurofeedback systems.

Pal P, Theisen DL, Datko M, van Lutterveld R, Roy A, Ruf A, Brewer JA.

Clin Neurophysiol. 2019 Mar;130(3):352-358. doi: 10.1016/j.clinph.2018.11.023. Epub 2018 Dec 16.

PMID:
30669011
4.

Can Mindfulness Address Maladaptive Eating Behaviors? Why Traditional Diet Plans Fail and How New Mechanistic Insights May Lead to Novel Interventions.

Brewer JA, Ruf A, Beccia AL, Essien GI, Finn LM, van Lutterveld R, Mason AE.

Front Psychol. 2018 Sep 10;9:1418. doi: 10.3389/fpsyg.2018.01418. eCollection 2018.

5.

Craving to Quit: A Randomized Controlled Trial of Smartphone app-based Mindfulness Training for Smoking Cessation.

Garrison KA, Pal P, O'Malley SS, Pittman BP, Gueorguieva R, Rojiani R, Scheinost D, Dallery J, Brewer JA.

Nicotine Tob Res. 2018 Jun 18. doi: 10.1093/ntr/nty126. [Epub ahead of print]

PMID:
29917096
6.

Mapping complex mind states: EEG neural substrates of meditative unified compassionate awareness.

Schoenberg PLA, Ruf A, Churchill J, Brown DP, Brewer JA.

Conscious Cogn. 2018 Jan;57:41-53. doi: 10.1016/j.concog.2017.11.003. Epub 2017 Nov 21.

PMID:
29169033
7.

Testing a mobile mindful eating intervention targeting craving-related eating: feasibility and proof of concept.

Mason AE, Jhaveri K, Cohn M, Brewer JA.

J Behav Med. 2018 Apr;41(2):160-173. doi: 10.1007/s10865-017-9884-5. Epub 2017 Sep 16.

8.

Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments.

Kober H, Brewer JA, Height KL, Sinha R.

Neuroimage. 2017 May 1;151:4-13. doi: 10.1016/j.neuroimage.2016.09.042. Epub 2016 Sep 28.

9.

Source-space EEG neurofeedback links subjective experience with brain activity during effortless awareness meditation.

van Lutterveld R, Houlihan SD, Pal P, Sacchet MD, McFarlane-Blake C, Patel PR, Sullivan JS, Ossadtchi A, Druker S, Bauer C, Brewer JA.

Neuroimage. 2017 May 1;151:117-127. doi: 10.1016/j.neuroimage.2016.02.047. Epub 2016 Feb 26.

10.

Development and Validation of the Behavioral Tendencies Questionnaire.

Van Dam NT, Brown A, Mole TB, Davis JH, Britton WB, Brewer JA.

PLoS One. 2015 Nov 4;10(11):e0140867. doi: 10.1371/journal.pone.0140867. eCollection 2015.

11.

Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework.

Loucks EB, Schuman-Olivier Z, Britton WB, Fresco DM, Desbordes G, Brewer JA, Fulwiler C.

Curr Cardiol Rep. 2015 Dec;17(12):112. doi: 10.1007/s11886-015-0668-7. Review.

12.

Mindfulness-Based Interventions for Weight Loss and CVD Risk Management.

Fulwiler C, Brewer JA, Sinnott S, Loucks EB.

Curr Cardiovasc Risk Rep. 2015 Oct;9(10). pii: 46. doi: 10.1007/s12170-015-0474-1. Epub 2015 Aug 29.

13.

Meditation leads to reduced default mode network activity beyond an active task.

Garrison KA, Zeffiro TA, Scheinost D, Constable RT, Brewer JA.

Cogn Affect Behav Neurosci. 2015 Sep;15(3):712-20. doi: 10.3758/s13415-015-0358-3.

14.

A randomized controlled trial of smartphone-based mindfulness training for smoking cessation: a study protocol.

Garrison KA, Pal P, Rojiani R, Dallery J, O'Malley SS, Brewer JA.

BMC Psychiatry. 2015 Apr 14;15:83. doi: 10.1186/s12888-015-0468-z.

15.

A Computational Account of Borderline Personality Disorder: Impaired Predictive Learning about Self and Others Through Bodily Simulation.

Fineberg SK, Steinfeld M, Brewer JA, Corlett PR.

Front Psychiatry. 2014 Aug 27;5:111. doi: 10.3389/fpsyt.2014.00111. eCollection 2014. Review.

16.

Optimizing real time fMRI neurofeedback for therapeutic discovery and development.

Stoeckel LE, Garrison KA, Ghosh S, Wighton P, Hanlon CA, Gilman JM, Greer S, Turk-Browne NB, deBettencourt MT, Scheinost D, Craddock C, Thompson T, Calderon V, Bauer CC, George M, Breiter HC, Whitfield-Gabrieli S, Gabrieli JD, LaConte SM, Hirshberg L, Brewer JA, Hampson M, Van Der Kouwe A, Mackey S, Evins AE.

Neuroimage Clin. 2014 Jul 10;5:245-55. doi: 10.1016/j.nicl.2014.07.002. eCollection 2014. Review.

17.

BOLD signal and functional connectivity associated with loving kindness meditation.

Garrison KA, Scheinost D, Constable RT, Brewer JA.

Brain Behav. 2014 May;4(3):337-47. doi: 10.1002/brb3.219. Epub 2014 Feb 12.

18.

Finding the right match: mindfulness training may potentiate the therapeutic effect of nonjudgment of inner experience on smoking cessation.

Schuman-Olivier Z, Hoeppner BB, Evins AE, Brewer JA.

Subst Use Misuse. 2014 Apr;49(5):586-94. doi: 10.3109/10826084.2014.850254.

19.

Why is it so hard to pay attention, or is it? Mindfulness, the factors of awakening and reward-based learning.

Brewer JA, Davis JH, Goldstein J.

Mindfulness (N Y). 2013 Mar 1;4(1). doi: 10.1007/s12671-012-0164-8.

20.

What about the "Self" is Processed in the Posterior Cingulate Cortex?

Brewer JA, Garrison KA, Whitfield-Gabrieli S.

Front Hum Neurosci. 2013 Oct 2;7:647. doi: 10.3389/fnhum.2013.00647. Review.

21.

The posterior cingulate cortex as a plausible mechanistic target of meditation: findings from neuroimaging.

Brewer JA, Garrison KA.

Ann N Y Acad Sci. 2014 Jan;1307:19-27. doi: 10.1111/nyas.12246. Epub 2013 Sep 13.

PMID:
24033438
22.

Effortless awareness: using real time neurofeedback to investigate correlates of posterior cingulate cortex activity in meditators' self-report.

Garrison KA, Santoyo JF, Davis JH, Thornhill TA 4th, Kerr CE, Brewer JA.

Front Hum Neurosci. 2013 Aug 6;7:440. doi: 10.3389/fnhum.2013.00440. eCollection 2013.

23.

Real-time fMRI links subjective experience with brain activity during focused attention.

Garrison KA, Scheinost D, Worhunsky PD, Elwafi HM, Thornhill TA 4th, Thompson E, Saron C, Desbordes G, Kober H, Hampson M, Gray JR, Constable RT, Papademetris X, Brewer JA.

Neuroimage. 2013 Nov 1;81:110-118. doi: 10.1016/j.neuroimage.2013.05.030. Epub 2013 May 17.

24.

Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use.

Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA 4th, Brewer JA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9. doi: 10.1016/j.drugalcdep.2012.11.015. Epub 2012 Dec 21.

25.

Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions.

Brewer JA, Elwafi HM, Davis JH.

Psychol Addict Behav. 2013 Jun;27(2):366-79. doi: 10.1037/a0028490. Epub 2012 May 28. Review.

26.

Meditation-induced changes in high-frequency heart rate variability predict smoking outcomes.

Libby DJ, Worhunsky PD, Pilver CE, Brewer JA.

Front Hum Neurosci. 2012 Mar 19;6:54. doi: 10.3389/fnhum.2012.00054. eCollection 2012.

27.

Meditation experience is associated with differences in default mode network activity and connectivity.

Brewer JA, Worhunsky PD, Gray JR, Tang YY, Weber J, Kober H.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20254-9. doi: 10.1073/pnas.1112029108. Epub 2011 Nov 23.

28.

Mindfulness training for smoking cessation: results from a randomized controlled trial.

Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, Carroll KM, Rounsaville BJ.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80. doi: 10.1016/j.drugalcdep.2011.05.027. Epub 2011 Jul 1.

29.

Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy.

Carroll KM, Kiluk BD, Nich C, Babuscio TA, Brewer JA, Potenza MN, Ball SA, Martino S, Rounsaville BJ, Lejuez CW.

Subst Use Misuse. 2011;46(1):23-34. doi: 10.3109/10826084.2011.521069.

31.

Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?

Brewer JA, Bowen S, Smith JT, Marlatt GA, Potenza MN.

Addiction. 2010 Oct;105(10):1698-706. doi: 10.1111/j.1360-0443.2009.02890.x.

32.

Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study.

Brewer JA, Sinha R, Chen JA, Michalsen RN, Babuscio TA, Nich C, Grier A, Bergquist KL, Reis DL, Potenza MN, Carroll KM, Rounsaville BJ.

Subst Abus. 2009 Oct-Dec;30(4):306-17. doi: 10.1080/08897070903250241.

33.

Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients.

Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN.

Biol Psychiatry. 2008 Dec 1;64(11):998-1004. doi: 10.1016/j.biopsych.2008.05.024. Epub 2008 Jul 17.

34.

Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.

Ghaznavi S, Nakic M, Rao P, Hu J, Brewer JA, Hannestad J, Bhagwagar Z.

Am J Psychiatry. 2008 Jul;165(7):813-8. doi: 10.1176/appi.ajp.2008.07111823. No abstract available.

PMID:
18593787
35.

Glucocorticoids and the osteoclast.

Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Patrick Ross F, Teitelbaum SL.

Ann N Y Acad Sci. 2007 Nov;1116:335-9. Review.

PMID:
18083935
36.

Dexamethsone suppresses bone formation via the osteoclast.

Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL.

Adv Exp Med Biol. 2007;602:43-6.

PMID:
17966386
37.

The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

Brewer JA, Potenza MN.

Biochem Pharmacol. 2008 Jan 1;75(1):63-75. Epub 2007 Jul 3. Review.

38.

Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase.

Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ.

Blood. 2007 May 15;109(10):4313-9. Epub 2007 Jan 25.

39.

The neurobiology of substance and behavioral addictions.

Grant JE, Brewer JA, Potenza MN.

CNS Spectr. 2006 Dec;11(12):924-30. Review.

PMID:
17146406
40.

Glucocorticoids suppress bone formation via the osteoclast.

Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL.

J Clin Invest. 2006 Aug;116(8):2152-60. Epub 2006 Jul 27.

41.

The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Smith SF, Simpson JM, Brewer JA, Sekhon LH, Biggs MT, Cook RJ, Little NS.

J Neurooncol. 2006 Oct;80(1):75-82. Epub 2006 Jun 23.

PMID:
16794749
42.
43.

Visualization of glucocorticoid receptor in the brain of green fluorescent protein-glucocorticoid receptor knockin mice.

Usuku T, Nishi M, Morimoto M, Brewer JA, Muglia LJ, Sugimoto T, Kawata M.

Neuroscience. 2005;135(4):1119-28. Epub 2005 Sep 8.

PMID:
16154291
44.

Genetic dissection of stress response pathways in vivo.

Boyle MP, Brewer JA, Vogt SK, Wozniak DF, Muglia LJ.

Endocr Res. 2004 Nov;30(4):859-63.

PMID:
15666837
45.

Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior.

Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ.

Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):473-8. Epub 2004 Dec 27.

46.

T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.

Brewer JA, Khor B, Vogt SK, Muglia LM, Fujiwara H, Haegele KE, Sleckman BP, Muglia LJ.

Nat Med. 2003 Oct;9(10):1318-22. Epub 2003 Aug 31.

PMID:
12949501
47.

Dissecting adrenal and behavioral responses to stress by targeted gene inactivation in mice.

Brewer JA, Bethin KE, Schaefer ML, Muglia LM, Vogt SK, Weninger SC, Majzoub JA, Muglia LJ.

Stress. 2003 Jun;6(2):121-5. Review.

PMID:
12775331
48.

Knock-ins and conditional knockouts: in vivo analysis of glucocorticoid receptor regulation and function.

Brewer JA, Vogt SK, Sleckman BP, Swat W, Kanagawa O, Muglia LJ.

Endocr Res. 2002 Nov;28(4):545-50.

PMID:
12530661
49.

The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development.

Kaplan F, Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T, Gagnon S, Asada M, Brewer JA, Sweezey NB.

Am J Respir Cell Mol Biol. 2003 Jan;28(1):33-41.

PMID:
12495930
50.

An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome.

Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM.

Development. 2002 Oct;129(19):4591-603.

Supplemental Content

Loading ...
Support Center